|
|
 Previous Article | Table of Contents | Next Article 
Effects of Cytokines on Platelet Production From Blood and Marrow
CD34+ Cells
Françoise Norol,
Natacha Vitrat,
Elisabeth Cramer,
Josette Guichard,
Samuel A. Burstein,
William Vainchenker, and
Najet Debili
From INSERM U 91, Hôpital Henri Mondor, Créteil, France.
The late stages of megakaryocytopoiesis, consisting of the terminal
processes of cytoplasmic maturation and platelet shedding, remain
poorly understood. A simple liquid culture system using CD34+ cells in serum-free medium has been developed to
study the regulation of platelet production in vitro. Platelets
produced in vitro were enumerated by flow cytometry. A truncated form
of human Mpl-Ligand conjugated to polyethylene glycol (PEG-rHuMGDF)
played a crucial role in both proplatelet formation and platelet
production. A combination of stem cell factor (SCF), interleukin-3
(IL-3), and IL-6 was as potent as PEG-rHuMGDF for the growth of
megakaryocytes (MKs). However, the number of proplatelet-displaying MKs
and platelets was increased 10-fold when PEG-rHuMGDF was used.
Peripheral blood mobilized CD34+ cells gave rise to a
threefold augmentation of platelets compared with marrow
CD34+ cells. This finding was related to the higher
proliferative capacity of the former population because the proportion
of proplatelet-displaying MKs was similar for both types of
CD34+ cells. The production of platelets per MK from
CD34+ cells was low, perhaps because of the low ploidy of
the cultured MKs. This defect in polyploidization correlated with the
degree of proliferation of MK progenitors induced by cytokines. In
contrast, ploidy development closer to that observed in marrow MKs was
observed in MKs derived from the low proliferative CD34+
CD41+ progenitors and was associated with a twofold to
threefold increment in platelet production per MK. As shown using this
CD34+ CD41+ cell population, PEG-rHuMGDF
was required throughout the culture period to potently promote platelet
production, but was not involved directly in the process of platelet
shedding. IL-3, SCF, and IL-6 alone had a very weak effect on
proplatelet formation and platelet shedding. Surprisingly, when used in
combination, these cytokines elicited a degree of platelet production
which was decreased only 2.4-fold in comparison with PEG-rHuMGDF. This
suggests that proplatelet formation may be inhibited by non-MK cells
which contaminate the cultures when the entire CD34+ cell
population is used. Cultured platelets derived from PEG-rHuMGDF- or
cytokine combination-stimulated cultures had similar ultrastructural features and a nearly similar response to activation by thrombin. The
data show that this culture system may be useful to study the effects
of cytokines and the role of polyploidization on platelet production
and function.
Blood, Vol. 91 No. 3 (February 1), 1998:
pp. 830-843
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Lordier, A. Jalil, F. Aurade, F. Larbret, J. Larghero, N. Debili, W. Vainchenker, and Y. Chang
Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling
Blood,
October 15, 2008;
112(8):
3164 - 3174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Zeuner, M. Signore, D. Martinetti, M. Bartucci, C. Peschle, and R. De Maria
Chemotherapy-Induced Thrombocytopenia Derives from the Selective Death of Megakaryocyte Progenitors and Can Be Rescued by Stem Cell Factor
Cancer Res.,
May 15, 2007;
67(10):
4767 - 4773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Chang, F. Aurade, F. Larbret, Y. Zhang, J.-P. Le Couedic, L. Momeux, J. Larghero, J. Bertoglio, F. Louache, E. Cramer, et al.
Proplatelet formation is regulated by the Rho/ROCK pathway
Blood,
May 15, 2007;
109(10):
4229 - 4236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Raslova, A. Kauffmann, D. Sekkai, H. Ripoche, F. Larbret, T. Robert, D. T. Le Roux, G. Kroemer, N. Debili, P. Dessen, et al.
Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach
Blood,
April 15, 2007;
109(8):
3225 - 3234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P.-N. Tsao, S.-C. Wei, Y.-N. Su, H.-C. Chou, C.-Y. Chen, and W.-S. Hsieh
Excess Soluble fms-Like Tyrosine Kinase 1 and Low Platelet Counts in Premature Neonates of Preeclamptic Mothers
Pediatrics,
August 1, 2005;
116(2):
468 - 472.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sabri, M. Jandrot-Perrus, J. Bertoglio, R. W. Farndale, V. M.-D. Mas, N. Debili, and W. Vainchenker
Differential regulation of actin stress fiber assembly and proplatelet formation by {alpha}2{beta}1 integrin and GPVI in human megakaryocytes
Blood,
November 15, 2004;
104(10):
3117 - 3125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Tenedini, M. E. Fagioli, N. Vianelli, P. L. Tazzari, F. Ricci, E. Tagliafico, P. Ricci, L. Gugliotta, G. Martinelli, S. Tura, et al.
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells
Blood,
November 15, 2004;
104(10):
3126 - 3135.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ungerer, M. Peluso, A. Gillitzer, S. Massberg, U. Heinzmann, C. Schulz, G. Munch, and M. Gawaz
Generation of Functional Culture-Derived Platelets From CD34+ Progenitor Cells to Study Transgenes in the Platelet Environment
Circ. Res.,
September 3, 2004;
95(5):
e36 - e44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Chang, P. A. Nakagawa, S. A. Williams, M. R. Schwartz, K. L. Imfeld, J. S. Buzby, and D. J. Nugent
Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro
Blood,
August 1, 2003;
102(3):
887 - 895.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Casella, T. Feccia, C. Chelucci, P. Samoggia, G. Castelli, R. Guerriero, I. Parolini, E. Petrucci, E. Pelosi, O. Morsilli, et al.
Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor
Blood,
February 15, 2003;
101(4):
1316 - 1323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. de Botton, S. Sabri, E. Daugas, Y. Zermati, J. E. Guidotti, O. Hermine, G. Kroemer, W. Vainchenker, and N. Debili
Platelet formation is the consequence of caspase activation within megakaryocytes
Blood,
July 30, 2002;
100(4):
1310 - 1317.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Mattia, F. Vulcano, L. Milazzo, A. Barca, G. Macioce, A. Giampaolo, and H. J. Hassan
Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release
Blood,
February 1, 2002;
99(3):
888 - 897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Baccini, L. Roy, N. Vitrat, H. Chagraoui, S. Sabri, J.-P. L. Couedic, N. Debili, F. Wendling, and W. Vainchenker
Role of p21Cip1/Waf1 in cell-cycle exit of endomitotic megakaryocytes
Blood,
December 1, 2001;
98(12):
3274 - 3282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Shivdasani
Molecular and Transcriptional Regulation of Megakaryocyte Differentiation
Stem Cells,
September 1, 2001;
19(5):
397 - 407.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Guerriero, G. Mattia, U. Testa, C. Chelucci, G. Macioce, I. Casella, P. Samoggia, C. Peschle, and H. J. Hassan
Stromal cell-derived factor 1{alpha} increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells
Blood,
May 1, 2001;
97(9):
2587 - 2595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Perez, H. M. Rinder, C. Wang, J. B. Tracey, N. Maun, and D. S. Krause
Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production
Blood,
March 15, 2001;
97(6):
1635 - 1643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-N. Willig, J. Breton-Gorius, C. Elbim, V. Mignotte, C. Kaplan, R. Mollicone, C. Pasquier, A. Filipe, F. Mielot, J.-P. Cartron, et al.
Macrothrombocytopenia with abnormal demarcation membranes in megakaryocytes and neutropenia with a complete lack of sialyl-Lewis-X antigen in leukocytes{---}a new syndrome?
Blood,
February 1, 2001;
97(3):
826 - 828.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Lepage, M. Leboeuf, J.-P. Cazenave, C. de la Salle, F. Lanza, and G. Uzan
The alpha IIbbeta 3 integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34+ cord blood cells to megakaryocytes
Blood,
December 15, 2000;
96(13):
4169 - 4177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Letestu, N. Vitrat, A. Masse, J.-P. L. Couedic, V. Lazar, P. Rameau, F. Wendling, J. Vuillier, P. Boutard, E. Plouvier, et al.
Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome
Blood,
March 1, 2000;
95(5):
1633 - 1641.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Gainsford, H. Nandurkar, D. Metcalf, L. Robb, C. G. Begley, and W. S. Alexander
The residual megakaryocyte and platelet production in c-Mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor
Blood,
January 15, 2000;
95(2):
528 - 534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Somlo, I. Sniecinski, A. ter Veer, J. Longmate, G. Knutson, S. Vuk-Pavlovic, R. Bhatia, W. Chow, L. Leong, R. Morgan, et al.
Recombinant Human Thrombopoietin in Combination With Granulocyte Colony-Stimulating Factor Enhances Mobilization of Peripheral Blood Progenitor Cells, Increases Peripheral Blood Platelet Concentration, and Accelerates Hematopoietic Recovery Following High-Dose Chemotherapy
Blood,
May 1, 1999;
93(9):
2798 - 2806.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Cohen-Solal, N. Vitrat, M. Titeux, W. Vainchenker, and F. Wendling
High-Level Expression of Mpl in Platelets and Megakaryocytes Is Independent of Thrombopoietin
Blood,
May 1, 1999;
93(9):
2859 - 2866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Sui, K. Tsuji, Y. Ebihara, R. Tanaka, K. Muraoka, M. Yoshida, K. Yamada, K. Yasukawa, T. Taga, T. Kishimoto, et al.
Soluble Interleukin-6 (IL-6) Receptor With IL-6 Stimulates Megakaryopoiesis From Human CD34+ Cells Through Glycoprotein (gp)130 Signaling
Blood,
April 15, 1999;
93(8):
2525 - 2532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Takahashi, N. Sekine, and T. Nakatake
Influence of Monoclonal Antiplatelet Glycoprotein Antibodies on In Vitro Human Megakaryocyte Colony Formation and Proplatelet Formation
Blood,
March 15, 1999;
93(6):
1951 - 1958.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Riviere, F. Subra, K. Cohen-Solal, V. Cordette-Lagarde, R. Letestu, C. Auclair, W. Vainchenker, and F. Louache
Phenotypic and Functional Evidence for the Expression of CXCR4 Receptor During Megakaryocytopoiesis
Blood,
March 1, 1999;
93(5):
1511 - 1523.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Taksin, J.-P. L. Couedic, I. Dusanter-Fourt, A. Masse, S. Giraudier, A. Katz, F. Wendling, W. Vainchenker, N. Casadevall, and N. Debili
Autonomous Megakaryocyte Growth in Essential Thrombocythemia and Idiopathic Myelofibrosis Is Not Related to a c-mpl Mutation or to an Autocrine Stimulation by Mpl-L
Blood,
January 1, 1999;
93(1):
125 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
